Manufacturer pages establish published offers, not independently verified fulfilment performance or clinic-specific access. No supplier quotations, contracts or patient-level records were reviewed. The live FDA shortage pages returned service errors; accessible FDA policy material and a published appellate opinion were found, but they are insufficient to certify current shortage or complete litigation status. A final disposition of the proposed 503B exclusions was not established. Recheck these points before a transaction or later publication.
Sources cited on this page
See the section’s source register for the research context.
Section sources →